Person

Susan Desmond-Hellmann

Director, Pfizer

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$634K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 18, 2017METASale209$144.67$30K
Feb 21, 2017METASale625$133.50$83K
Nov 18, 2016METASale625$118.33$74K
Aug 18, 2016METASale625$124.01$78K
May 19, 2016METASale2,514$117.07$294K
May 10, 2016METASale625$119.52$75K

SEC reporting-owner ID (CIK) 1507911 · all filings on EDGAR